Adial Pharmaceuticals

Website
1001 Research Park Blvd Ste 100
Charlottesville, VA 22911

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company based in Charlottesville, VA, dedicated to developing treatments for addictions and other unmet medical needs. Their lead investigational drug candidate, AD04, is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD) currently undergoing a pivotal Phase 3 clinical trial.

Under the leadership of CEO Cary Claiborne, Adial Pharmaceuticals is focused on advancing precision medicine approaches in substance use treatment, with a particular emphasis on addressing the challenges of AUD through innovative research and development efforts.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesVirginiaCharlottesvilleAdial Pharmaceuticals

Partial Data by Infogroup (c) 2025. All rights reserved.